These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload. Liu Y, Yu M, Wu L, Chin MT. Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2082-92. PubMed ID: 20382855 [Abstract] [Full Text] [Related]
11. Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes. Wu L, Chien WM, Hartman ME, Moussavi-Harami F, Liu Y, Chin MT. Biochem Biophys Res Commun; 2011 Dec 02; 415(4):662-8. PubMed ID: 22079635 [Abstract] [Full Text] [Related]
12. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Sakata Y, Xiang F, Chen Z, Kiriyama Y, Kamei CN, Simon DI, Chin MT. Arterioscler Thromb Vasc Biol; 2004 Nov 02; 24(11):2069-74. PubMed ID: 15345511 [Abstract] [Full Text] [Related]
13. CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6. Shirvani S, Xiang F, Koibuchi N, Chin MT. Biochem Biophys Res Commun; 2006 Jan 06; 339(1):151-6. PubMed ID: 16293227 [Abstract] [Full Text] [Related]
14. Transcription Factor CHF1/Hey2 Regulates Specific Pathways in Serum Stimulated Primary Cardiac Myocytes: Implications for Cardiac Hypertrophy. Yu M, Xiang F, Beyer RP, Farin FM, Bammler TK, Chin MT. Curr Genomics; 2010 Jun 06; 11(4):287-96. PubMed ID: 21119893 [Abstract] [Full Text] [Related]
15. Differential Wnt-mediated programming and arrhythmogenesis in right versus left ventricles. Li G, Khandekar A, Yin T, Hicks SC, Guo Q, Takahashi K, Lipovsky CE, Brumback BD, Rao PK, Weinheimer CJ, Rentschler SL. J Mol Cell Cardiol; 2018 Oct 06; 123():92-107. PubMed ID: 30193957 [Abstract] [Full Text] [Related]
16. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C, Bartkowiak S, Borggrefe M, Schimpf R, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen R, Tfelt-Hansen J, Olesen MS, Kääb S, Beckmann BM, Weeke P, Watanabe H, Endo N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T, Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel R, Coronel R, Boukens BJ, Bézieau S, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DM, Christoffels VM, Le Marec H, Wilde AA, Probst V, Schott JJ, Dina C, Redon R. Nat Genet; 2013 Sep 06; 45(9):1044-9. PubMed ID: 23872634 [Abstract] [Full Text] [Related]
17. Cardiomyocyte-specific deletion of survivin causes global cardiac conduction defects. Schrickel JW, Lickfett L, Lewalter T, Tiemann K, Nickenig G, Baba H, Heusch G, Schulz R, Levkau B. Basic Res Cardiol; 2012 Nov 06; 107(6):299. PubMed ID: 22976005 [Abstract] [Full Text] [Related]